lopinavir has been researched along with Latent Tuberculosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobs, BA; Mtshali, S | 1 |
| Decloedt, EH; Maartens, G; McIlleron, H; van der Walt, JS; Wiesner, L | 1 |
1 trial(s) available for lopinavir and Latent Tuberculosis
| Article | Year |
|---|---|
The pharmacokinetics of lopinavir/ritonavir when given with isoniazid in South African HIV-infected individuals.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Area Under Curve; Biological Availability; Disease Progression; Drug Combinations; Drug Interactions; Female; HIV Infections; Humans; Isoniazid; Latent Tuberculosis; Lopinavir; Male; Ritonavir; South Africa | 2015 |
1 other study(ies) available for lopinavir and Latent Tuberculosis
| Article | Year |
|---|---|
A Comparative Analysis of Physiologically Based Pharmacokinetic Models for Human Immunodeficiency Virus and Tuberculosis Infections.
Topics: Anti-Retroviral Agents; HIV; HIV Infections; Humans; Latent Tuberculosis; Lopinavir; Models, Biological; Rifampin; Ritonavir; Tuberculosis | 2022 |